Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT: A Double Blind, Placebo Controlled, Randomized Feasibility Study Protocol

NCT04661475 is registered in ClinicalTrials.gov with Sultan Qaboos University as lead sponsor.

NCT NCT04661475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04661475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT: A Double Blind, Placebo Controlled, Randomized Feasibility Study Protocol
Lead sponsor
Sultan Qaboos University
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2021
Completion date
March 2, 2023
Enrollment
76 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major